Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"I couldn't carry on taking a drug like that": A qualitative study of patient perspectives on side effects from rheumatology drugs.
Berthelsen DB, Nielsen SM, Rasmussen MU, Voshaar M, Richards P, Bartlett SJ, Hazlewood GS, Shea BJ, Tugwell P, Ellingsen T, Jørgensen TS, Kristensen S, Simon LS, Christensen R, Flurey CA; OMERACT Safety Working Group. Berthelsen DB, et al. Among authors: voshaar m. Rheumatology (Oxford). 2024 Apr 13:keae223. doi: 10.1093/rheumatology/keae223. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38613847
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group.
Kordkheili AM, Bekker C, Hoens AM, Voshaar M, Campbell W, Carmona L, de Wit M, March L, Nielsen SM, Shea BJ, Toupin-April K, Tugwell P, Tymms K, Kelly A; Adherence Working Group. Kordkheili AM, et al. Among authors: voshaar m. Semin Arthritis Rheum. 2024 Jun;66:152411. doi: 10.1016/j.semarthrit.2024.152411. Epub 2024 Feb 13. Semin Arthritis Rheum. 2024. PMID: 38537323
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
Décary S, de Wit M, Naye F, Barton JL, Fraenkel L, Li LC, Brooks P, Stacey D, Maxwell LJ, Campbell W, Hofstetter C, Voshaar M, Meara A, Christensen R, Boonen A, Suarez-Almazor ME, Meade T, March L, Jull JE, Alten R, Morgan EM, Stewart Hazlewood G, Barber CEH, Guillemin F, El-Miedany Y, Mittoo S, Robertson TW, Bartlett SJ, Singh JA, Mannion M, Nasef SI, Boel A, Adebajo A, Arnaud L, Gill TK, Moholt E, Burt J, Jayatilleke A, Hmamouchi I, Berthelsen DB, Blanco FJ, Mather K, Maharaj A, Sharma S, Caso F, Beaton D, Shea B, Fong C, Fernandez AP, Mackie S, Nikiphorou E, Jones A, Greer-Smith R, Sloan VS, Akpabio A, Strand V, Lee RR, Umaefulam V, Monti S, Abaza N, Schultz G, Stones S, Gossec L, Nielsen SM, Cavallo S, Srinivasalu H, Constien D, Evans V, Tugwell P, Toupin-April K. Décary S, et al. Among authors: voshaar m. Semin Arthritis Rheum. 2024 Apr;65:152381. doi: 10.1016/j.semarthrit.2024.152381. Epub 2024 Jan 15. Semin Arthritis Rheum. 2024. PMID: 38306813
Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative.
Weinbrecht-Mischkewitz M, Kamal M, Asim F, Guillemin F, Goel N, Voshaar M, Boonen A, Berthelsen DB, Toupin-April K, Lopez-Olivo MA, Sloan VS, Boers M, Jones CA, van der Horst-Bruinsma I, Cashin AG, Sharma S, Leong A, Alten R, Shea B, March L, Tugwell P, Christensen R, Nielsen SM; Contextual Factors Working Group. Weinbrecht-Mischkewitz M, et al. Among authors: voshaar m. Semin Arthritis Rheum. 2024 Apr;65:152370. doi: 10.1016/j.semarthrit.2024.152370. Epub 2024 Jan 10. Semin Arthritis Rheum. 2024. PMID: 38290371 Free article.
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
Berthelsen DB, Simon LS, Ioannidis JPA, Voshaar M, Richards P, Goel N, Strand V, Nielsen SM, Shea BJ, Tugwell P, Bartlett SJ, Hazlewood GS, March L, Singh JA, Suarez-Almazor ME, Boers M, Stevens RM, Furst DE, Woodworth T, Leong A, Brooks PM, Flurey C, Christensen R; OMERACT Safety Working Group. Berthelsen DB, et al. Among authors: voshaar m. Semin Arthritis Rheum. 2023 Dec;63:152288. doi: 10.1016/j.semarthrit.2023.152288. Epub 2023 Oct 26. Semin Arthritis Rheum. 2023. PMID: 37918049
Correction: Development of a standard set of PROs and generic PROMs for Dutch medical specialist care.
Voshaar MO, Terwee CB, Haverman L, van der Kolk B, Harkes M, van Woerden CS, van Breda F, Breukink S, de Hoop I, Vermeulen H, de Graaf E, Hazelzet J, van Leiden B, Stienen J, Hoekstra M, Bart H, van Bommel H, Determann D, Verburg M, van der Wees P, Beurskens AJ. Voshaar MO, et al. Qual Life Res. 2023 Jun;32(6):1607. doi: 10.1007/s11136-023-03412-2. Qual Life Res. 2023. PMID: 37022586 Free PMC article. No abstract available.
Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration.
Thomas M, Marshall DA, Sanchez AL, Bartlett SJ, Boonen A, Fraenkel L, Proulx L, Voshaar M, Bansback N, Buchbinder R, Guillemin F, Hiligsmann M, Richards DP, Richards P, Shea B, Tugwell P, Falahee M, Hazlewood GS. Thomas M, et al. Among authors: voshaar m. Semin Arthritis Rheum. 2023 Feb;58:152112. doi: 10.1016/j.semarthrit.2022.152112. Epub 2022 Nov 3. Semin Arthritis Rheum. 2023. PMID: 36372015 Free article.
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases.
Kastrati K, Aletaha D, Burmester GR, Chwala E, Dejaco C, Dougados M, McInnes IB, Ravelli A, Sattar N, Stamm TA, Takeuchi T, Trauner M, van der Heijde D, Voshaar MJH, Winthrop K, Smolen JS, Kerschbaumer A. Kastrati K, et al. Among authors: voshaar mjh. RMD Open. 2022 Sep;8(2):e002359. doi: 10.1136/rmdopen-2022-002359. RMD Open. 2022. PMID: 36260501 Free PMC article.
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.
Hartman L, da Silva JAP, Buttgereit F, Cutolo M, Opris-Belinski D, Szekanecz Z, Masaryk P, Voshaar MJH, Heymans MW, Lems WF, van der Heijde DMFM, Boers M. Hartman L, et al. Among authors: voshaar mjh. Rheumatology (Oxford). 2023 May 2;62(5):1824-1833. doi: 10.1093/rheumatology/keac547. Rheumatology (Oxford). 2023. PMID: 36165675 Free PMC article. Clinical Trial.
52 results